TrialMarine drugs2022

Improved Plasma Lipids, Anti-Inflammatory Activity, and Microbiome Shifts in Overweight Participants: Two Clinical Studies on Oral Supplementation with Algal Sulfated Polysaccharide.

Lauren A Roach et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.